Both in Biotechnology
IN8bio vs Scilex Holding
Over the past year INAB returned −51.6% and SCLX returned −89.5%; their daily moves had a correlation of 0.12.
INAB −51.6% SCLX −89.5%Growth of $1, one year, split-adjusted
| Metric | INAB | SCLX |
|---|---|---|
| Price | $0.9100 | $1.87 |
| Market cap | $9.0M | $13.2M |
| Today | +0.97% | +1.08% |
| 1 month | −35.0% | −53.9% |
| 6 months | −43.5% | −83.2% |
| Year to date | −61.1% | −84.7% |
| 1 year | −54.3% | −89.6% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | — | 51.9% |
| Net margin | — | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $17.8M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 84.0% | 70.4% |
| Short % of float | 0.5% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).